Literature DB >> 2786724

Epidermal tumour necrosis factor alpha and interleukin 6-like activities in AIDS-related Kaposi's sarcoma. An immunohistological study.

A Oxholm1, P Oxholm, H Permin, K Bendtzen.   

Abstract

Biopsies from 6 patients with AIDS and Kaposi's sarcoma (KS) in the tumour stage, and 6 healthy controls, were immunohistologically examined for the presence of tissue-bound tumour necrosis factor alpha (TNF alpha) and interleukin 6 (IL-6) in the skin. TNF alpha was demonstrated using specific polyclonal antiserum to human recombinant TNF alpha. IL-6 was visualized indirectly using a polyclonal antiserum to partially purified human crude supernatants of activated human blood monocytes, followed by absorption with recombinant human IL-6. The cytokines were found identically located in epidermal cell membranes in stratum granulosum and spinosum of the epidermis from unaffected skin in both AIDS patients and in controls. Biopsies from KS elements showed markedly increased epidermal staining for both TNF delta and IL-6. It was not possible to detect TNF alpha or IL6 in the endothelial cells of the tumour. The observation of increased amounts of epidermal-bound TNF alpha and IL-6 in AIDS-related KS elements supplements previous studies indicating that the skin plays an active immunoinflammatory role in patients with AIDS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786724     DOI: 10.1111/j.1699-0463.1989.tb00827.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  9 in total

1.  Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.

Authors:  V Fiorelli; R Gendelman; F Samaniego; P D Markham; B Ensoli
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

2.  Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.

Authors:  Olsi Gjyshi; Stephanie Flaherty; Mohanan Valiya Veettil; Karen E Johnson; Bala Chandran; Virginie Bottero
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

Review 3.  Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.

Authors:  Giovanni Barillari; Barbara Ensoli
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

4.  A possible role of multidrug resistance-associated protein (MRP) in basic fibroblast growth factor secretion by AIDS-associated Kaposi's sarcoma cells: a survival molecule?

Authors:  S Gupta; S Aggarwal; S Nakamura
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

5.  Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acid.

Authors:  Laurie T Krug; Veronika P Pozharskaya; Yimin Yu; Naoki Inoue; Margaret K Offermann
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation.

Authors:  Patrick A Carroll; Elizabeth Brazeau; Michael Lagunoff
Journal:  Virology       Date:  2004-10-10       Impact factor: 3.616

7.  Angiogenic properties of human immunodeficiency virus type 1 Tat protein.

Authors:  A Albini; G Barillari; R Benelli; R C Gallo; B Ensoli
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

8.  Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication.

Authors:  Mi-Kyung Park; Hyejeong Cho; Seong Woon Roh; Seong-Jun Kim; Jinjong Myoung
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

Review 9.  Cytokine-Targeted Therapeutics for KSHV-Associated Disease.

Authors:  Nedaa Alomari; Jennifer Totonchy
Journal:  Viruses       Date:  2020-09-28       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.